David Sherman

1.1k total citations
34 papers, 835 citations indexed

About

David Sherman is a scholar working on Epidemiology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, David Sherman has authored 34 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Pathology and Forensic Medicine and 13 papers in Hepatology. Recurrent topics in David Sherman's work include Liver Disease Diagnosis and Treatment (16 papers), Liver Disease and Transplantation (13 papers) and Alcohol Consumption and Health Effects (11 papers). David Sherman is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Liver Disease and Transplantation (13 papers) and Alcohol Consumption and Health Effects (11 papers). David Sherman collaborates with scholars based in United Kingdom, United States and Austria. David Sherman's co-authors include Shaul G. Massry, Hartmut H. Malluche, Anthony W. Norman, Robert J. Williams, T. J. Peters, Roger Williams, David A. Goldstein, Roger Williams, S. G. Massry and H H Malluche and has published in prestigious journals such as The Lancet, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David Sherman

33 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sherman United Kingdom 15 304 260 184 165 150 34 835
Peter Oelzner Germany 19 228 0.8× 133 0.5× 186 1.0× 19 0.1× 259 1.7× 92 1.1k
Amal El‐Shehaby Egypt 14 72 0.2× 105 0.4× 42 0.2× 41 0.2× 179 1.2× 24 693
Dan‐Qin Sun China 14 138 0.5× 525 2.0× 18 0.1× 211 1.3× 194 1.3× 33 848
Daniel Flores United States 15 59 0.2× 288 1.1× 19 0.1× 117 0.7× 246 1.6× 29 853
Rebeca Reyes‐García Spain 18 209 0.7× 120 0.5× 472 2.6× 11 0.1× 475 3.2× 84 1.3k
Anja Urbschat Germany 17 83 0.3× 74 0.3× 67 0.4× 16 0.1× 202 1.3× 34 808
Afroditi Katsaraki Greece 15 50 0.2× 121 0.5× 16 0.1× 96 0.6× 160 1.1× 32 943
Catherine Fortier Canada 15 97 0.3× 72 0.3× 31 0.2× 24 0.1× 67 0.4× 46 792
Emilio Orfei United States 13 187 0.6× 78 0.3× 26 0.1× 16 0.1× 126 0.8× 18 684

Countries citing papers authored by David Sherman

Since Specialization
Citations

This map shows the geographic impact of David Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sherman more than expected).

Fields of papers citing papers by David Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sherman. The network helps show where David Sherman may publish in the future.

Co-authorship network of co-authors of David Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of David Sherman. A scholar is included among the top collaborators of David Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sherman. David Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perry, Robert, et al.. (2022). Liver injury following the treatment of a duodenal varix with histoacryl glue. Gastrointestinal Endoscopy. 96(4). 688–689.
2.
Sherman, David, Phillip Lung, & P J Shorvon. (2016). Virtual touch quantification (VTq) elastography for non-invasive assessment of liver disease and its complications: what the clinician needs to know. Frontline Gastroenterology. 8(1). 37–44. 5 indexed citations
3.
4.
Ashrafian, Hutan, Antonio Navarro‐Sánchez, Thanos Athanasiou, David Sherman, & Alberto Isla. (2014). Thoracoscopic Esophageal Repair of a Spontaneous Barrett's Ulcer Perforation. The Annals of Thoracic Surgery. 99(1). 331–333. 2 indexed citations
5.
6.
Agarwal, Anil, David Patch, Susan E. Davies, et al.. (2001). Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure. European Journal of Gastroenterology & Hepatology. 13(1). 71–73. 14 indexed citations
7.
Raja, K.B., Adrian Bomford, Robert Przemioslo, et al.. (1996). A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis.. Gut. 38(5). 765–769. 31 indexed citations
8.
Kapczinski, Flávio, et al.. (1995). Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients. Psychopharmacology. 120(2). 220–226. 12 indexed citations
9.
Ball, David M., David Sherman, John Powell, et al.. (1995). No association between the c2 allele at the cytochrome P450IIE1 gene and alcohol induced liver disease, alcohol Korsakoff's syndrome or alcohol dependence syndrome. Drug and Alcohol Dependence. 39(3). 181–184. 11 indexed citations
10.
Sherman, David & Roger Williams. (1995). LIVER TRANSPLANTATION AND THE ALCOHOLIC PATIENT. Alcohol and Alcoholism. 30(2). 141–3. 29 indexed citations
11.
Sherman, David & Robert J. Williams. (1994). Liver damage: mechanisms and management. British Medical Bulletin. 50(1). 124–138. 22 indexed citations
12.
Wassif, W, David Sherman, J R Salisbury, & T. J. Peters. (1994). Use of Dynamic Tests of Muscle Function and Histomorphometry of Quadriceps Muscle Biopsies in the Investigation of Patients with Chronic Alcohol Misuse and Chronic Fatigue Syndrome. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 31(5). 462–468. 8 indexed citations
13.
Howard, Louise M., Thomas Fahy, Philip Wong, et al.. (1994). Psychiatric outcome in alcoholic liver transplant patients. QJM. 87(12). 731–736. 61 indexed citations
14.
Sherman, David, Roberta J. Ward, Akira Yoshida, & T. J. Peters. (1994). Alcohol and acetaldehyde dehydrogenase gene polymorphism and alcoholism. Birkhäuser Basel eBooks. 71. 291–300. 10 indexed citations
15.
Sherman, David, Roberta J. Ward, Margaret Warren-Perry, Roger Williams, & T. J. Peters. (1993). Association of restriction fragment length polymorphism in alcohol dehydrogenase 2 gene with alcohol induced liver damage.. BMJ. 307(6916). 1388–1390. 24 indexed citations
16.
Teare, Julian, Simon Greenfield, R. P. H. Thompson, et al.. (1993). Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. The Lancet. 342(8876). 895–898. 87 indexed citations
17.
Sherwood, Roy, et al.. (1993). Total pancreatic and salivary serum iso-amylase activities in alcohol misusers in relapse and remission and in alcoholic liver disease. Clinica Chimica Acta. 223(1-2). 169–172. 8 indexed citations
18.
Sherman, David, Roberta J. Ward, & T. J. Peters. (1993). The Role of Alcohol and Aldehyde Dehydrogenases In Alcohol-Related Diseases: Clinical Studies of Molecular Markers. Advances in experimental medicine and biology. 328. 555–560. 2 indexed citations
19.
Sherman, David, et al.. (1993). Diverse polymorphism within a short coding region of the human aldehyde dehydrogenase-5 (ALDH5) gene. Human Genetics. 92(5). 477–480. 13 indexed citations
20.
Glassock, Richard J., David A. Goldstein, David Sherman, Jorge Rakela, & Michael N. Koss. (1982). Nephrotic Syndrome in a Patient with Liver Disease. American Journal of Nephrology. 2(1). 40–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Oelzner Breakdown of academic impact, for papers by Amal El‐Shehaby Breakdown of academic impact, for papers by Dan‐Qin Sun Breakdown of academic impact, for papers by Daniel Flores Breakdown of academic impact, for papers by Rebeca Reyes‐García Breakdown of academic impact, for papers by Anja Urbschat Breakdown of academic impact, for papers by Afroditi Katsaraki Breakdown of academic impact, for papers by Catherine Fortier Breakdown of academic impact, for papers by Emilio Orfei
Rankless by CCL
2026